Emergence of Influenza A H1N2 Reassortant Viruses in the Human Population during 2001  by Gregory, V. et al.
Virology 300, 1–7 (2002)RAPID COMMUNICATION
Emergence of Influenza A H1N2 Reassortant Viruses in the Human Population during 2001
V. Gregory,* M. Bennett,* M. H. Orkhan,† S. Al Hajjar,‡ N. Varsano,§ E. Mendelson,§
M. Zambon,¶ J. Ellis,¶ A. Hay,* and Y. P. Lin*,1
*Virology Division, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, United Kingdom; †Egyptian Organization
for Biological Products and Vaccines, 51 St. Wezaret El-Zeraa, Agouza, Cairo, Egypt; ‡Pediatric Infectious Diseases, Department of Pediatrics,
King Faisal Specialist Hospital and Research Centre, P. O. Box 3354, Riyadh 11211, Kingdom of Saudi Arabia; §Central Virology Laboratory,
Public Health Laboratories, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel; and ¶Respiratory Virus Unit,
PHLS Central Public Health Laboratory, 61 Colindale Avenue, London, NW9 5HT, United Kingdom
Received March 12, 2002; returned to author for revision April 12, 2002; accepted April 29, 2002
Influenza A H1N2 viruses, which emerged during 2001, are genetic reassortants between H1N1 and H3N2 subtype viruses
which have cocirculated in the human population since 1977. They possess a H1 hemagglutinin antigenically and genetically
similar to contemporary A/New Caledonia/20/99 (H1N1)-like viruses and seven genes closely related to those of recent
A/Moscow/10/99 (H3N2)-like viruses. The viruses have spread to many regions of the world and have predominated over
H1N1 viruses in several countries. Since half of the amino acid changes which accumulated in the HAs of H1N1 viruses since
1995 are in residues implicated in receptor binding, functional changes in the H1 HA may have facilitated its replacement ofSince the reemergence of influenza A H1N1 subtype
viruses in the human population in 1977 (1, 2), they have
cocirculated throughout the world with viruses of the
H3N2 subtype. Although genetic reassortants between
viruses of these two subtypes have circulated for brief
periods, they did not become established in the human
population. A/California/10/78-like reassortant H1N1 vi-
ruses containing the M and NS genes together with the
HA and NA of H1N1 viruses and the polymerase complex
(PB1, PB2, PA, and NP) of H3N2 viruses circulated in
various countries around the world from 1978 to 1980 (3,
4). These viruses did not remain prevalent and subse-
quent H1N1 viruses, represented by the variant A/En-
gland/333/80, were essentially free of H3N2 genes (5).
Between December 1988 and March 1989, H1N2 viruses,
deriving seven genes from H3N2 viruses, were isolated
from sporadic cases in China (6). These viruses were not
observed to spread outside China or to persist. Recently
(December 2001 to February 2002), H1N2 reassortant
viruses, with a similar complement of H1N1 and H3N2
virus genes, were associated with outbreaks of influenza
in Egypt, Israel, and the U.K. (7). Following the initial
observations of their prevalence in these countries,
H1N2 viruses were subsequently shown to be circulating1in various parts of the world, including countries in Af-
rica, America, Asia, and Europe (8). The close relation-
ships between the H1 and seven “H3N2” genes of the
H1N2 viruses and the corresponding genes of recent
H1N1 and H3N2 viruses, reported here, indicate that the
H1N2 viruses arose by genetic reassortment between
recently cocirculating viruses, between 1999 and 2001.
Furthermore, the observation that half of the amino acid
changes which distinguish recent A/New Caledonia/20/
99-like HAs from the HAs of early A/Beijing/262/95-like
viruses are in residues which may influence receptor
binding raises the possibility that these and other
changes may have facilitated the replacement of the H3
by the H1 hemagglutinin and the emergence of epide-
miologically successful viruses.
Results. Prevalence of H1N2 viruses. The earliest ex-
amples, identified retrospectively, were two H1N2 vi-
ruses isolated in Saudi Arabia in March 2001, at a time
when H1N1 viruses had predominated (relative to H3N2
and B viruses) in countries of the Northern hemisphere
during the winter of 2000 to 2001. Of the H1 viruses
subsequently isolated in Egypt, Israel, and the United
Kingdom from August 2001 to February 2002, the majority
of those characterized were of the H1N2 subtype. On the
other hand, H1 viruses were isolated only sporadically inthe H3 HA and may contribute to the future epidemiologic
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Latvia, Portugal, Sweden, and Switzerland, whereas the
few H1 viruses isolated in Italy and Spain were H1N1.
H1N2 viruses have also been isolated in North America
(U.S.A. and Canada) and other countries in Asia, includ-
ing India, Malaysia, Oman, and Singapore (8). These
viruses are therefore widespread geographically and
have been associated with outbreaks of influenza in
different countries. Infections by H1N2 viruses occurred
mainly among the 5 to 15 age groups in Egypt, Israel, and
the U.K.; no unusual clinical picture was observed.
Antigenic Characteristics. Hemagglutination inhibition
(HI) tests using postinfection ferret antisera to reference
strains, A/New Caledonia/20/99 (H1N1) and A/Madagas-
car/55794/00 (H1N1), representative of recently circulat-
ing H1N1 viruses, showed that the hemagglutinins (HAs)
of the H1N2 viruses were antigenically closely related to
those of recent A/New Caledonia/20/99 (H1N1)-like vi-
ruses (Table 1). They were clearly distinguished from the
previous antigenic variant A/Beijing/262/95 (H1N1), and
from A/Bayern/7/95 (H1N1), which is a recent represen-
tative of the other antigenically and genetically distinct
lineage of H1N1 viruses (Table 1, Fig. 1A) (9, 10). Neur-
aminidase inhibition (NI) by hyperimmune rabbit antisera
to human H3N2 viruses, such as A/Port Chalmers/1/73
and A/Beijing/32/92, and postinfection ferret sera to re-
cent H3N2 isolates, such as A/Moscow/10/99 and
A/Egypt/96/02 (H1N2), showed that the NAs of H1N2
viruses were closely related to those of H3N2 viruses
circulating recently in the human population (data not
shown).
Genetic Relationships between H1N2, H1N1, and
H3N2 Viruses. Partial sequence analyses of the eight
genes of a number of H1N2 viruses from different coun-
tries (Table 2) showed that the reassortants possessed
similar genome compositions, comprising a H1 gene
close to that of A/New Caledonia/20/99-like H1N1 vi-
ruses (sequence similarity 98.4–99.0%) and seven genes
closely related to the corresponding genes of recently
circulating H3N2 viruses, represented by A/Moscow/
10/99 (sequence similarity greater than 98%). Table 3
shows the sequence similarities between the corre-
sponding genes of the earliest H1N2 isolate, A/Saudi
Arabia/2231/01, a contemporary H1N1 isolate, A/Saudi
Arabia/7971/00, and the current prototype vaccine
strains, A/New Caledonia/20/99 (H1N1) and A/Moscow/
10/99 (H3N2). The six internal genes of H1N2 viruses
were clearly distinguishable from the corresponding
genes of contemporary H1N1 viruses, 78–92% sequence
similarity.
The sequences of the HA genes of H1N2 isolates from
the five different countries were similar and on the phy-
logenetic tree (Fig. 1A) formed a cluster, closely related
to the HA of A/New Caledonia/20/99 and distinct from
the A/Bayern/7/95 lineage. Of the two antigenically sim-
TABLE 1
Antigenic Relationships between the Hemagglutinins of H1N1 and H1N2 Viruses
Virus Isolation date
Hemagglutination inhibition titrea
Postinfection ferret sera
A/Bay
7/95
A/Beij
262/95
A/NC
20/99
A/HK
1252/00
A/Mad
57794/00
H1N1
A/Bayern/7/95 2560 320 40  40
A/Beijing/262/95 80 2560 640 40 640
A/New Caledonia/20/99 40 320 1280 160 1280
A/Hong Kong/1252/00  40 160 640 160
A/Madagascar/57794/00 40 320 1280 160 1280
A/Saudi Arabia/7971/00 05/12/00 80 160 1280 160 1280
A/Israel/149/01 07/03/01  80 1280 40 1280
A/Hong Kong/1273/01 29/08/01 40 320 1280 160 1280
A/Madrid/G1216/02 08/01/02 80 320 1280 160 1280
A/Ireland/649/02 12/01/02 40 160 640 80 640
A/Lisbon/1/02 14/01/02  80 640 80 640
H1N2
A/Saudi Arabia/2231/01 17/03/01 40 160 1280 160 1280
A/Israel/152/01 13/08/01  80 640 80 640
A/Egypt/57/01 25/11/01  80 320 40 320
A/England/2/02 03/01/02  160 1280 160 1280
A/Latvia/656/02 18/01/02  80 640 160 1280
A/Lyon/CHU/1575/02 20/01/02  80 640 80 640
a Reference viruses and homologous titres are in bold. ; 40.
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ilar, but genetically distinguishable, variants among re-
cent A/New Caledonia/20/99 (H1N1)-like viruses, the
HAs of H1N2 viruses were more closely related to those
of the variant group represented by e.g., A/Saudi Arabia/
7971/00 or A/Egypt/101/01, with which they share the
change V169A (relative to A/New Caledonia/20/99), than
to the HAs of viruses represented by A/Madagascar/
57794/00, characterized by the changes E126G and
K166M (numbered according to H3 HA). Two amino acid
differences relative to A/New Caledonia/20/99, A193T
and A218T, were characteristic of the HAs of the H1N2
viruses and proved to be a useful diagnostic signature
for the identification of H1N2 viruses in the absence of
data on NA, in particular the earlier 2001 isolates from
Saudi Arabia; a third difference V178I was present in
many of the H1 sequences of UK isolates.
Also indicated on the phylogenetic tree are the amino
acid changes (numbered according to H3) progressively
accumulated in H1 HAs from early A/Beijing/262/95-like
viruses to recent A/New Caledonia/20/99-like viruses. Of
the eight changes, S78L, T136S, E156G, V169A, S186P,
I194L, N275D, and T312A, accumulated in the HAs of the
H1N2 viruses, four residues, 136, 156, 186, and 194, in
addition to 193, in the receptor binding sites of H3, H5,
and/or H9 HAs interact with the bound receptor (11–13).
The NA sequences of H1N2 viruses were closely re-
lated to that of A/Moscow/10/99, and a more recent
variant, represented by A/Singapore/15/01, with which
they share a single common amino acid difference,
P267L, from the sequence of A/Moscow/10/99 (Fig. 1B).
The phylogenetic tree also shows that they are more
distantly related to the NAs of other recent H3N2 genetic
variants, such as those represented by A/Lyon/1242/00
and A/Toulouse/878/01. Two further differences (from
FIG. 1. Phylogenetic relationships between the genes of H1N2, H1N1, and H3N2 human influenza viruses. Sequences encoding HA1 of H1 (A,
nucleotides 57–1026), N2 (B, nucleotides 366-1366), NP (C, nucleotides 966-1338), and M1 and M2 proteins (D, nucleotides 129–832) were analyzed
with PAUP using a maximum parsimony algorithm. The lengths of the horizontal lines are proportional to the number of nucleotide differences, as
indicated by the bar. Vaccine strains are shown in bold typeface. Common amino acid changes accumulated during evolution are indicated in A;
numbering of H1 residues in A is according to H3 HA.
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that of A/Moscow/10/99) common to the sequences of
H1N2 viruses, E199K and K431N, reflect their divergence
from the NAs of H3N2 viruses.
It is apparent from the genetic relationships between
the HA and NA components of the H1N2 viruses and
variants of H1N1 and H3N2 viruses which emerged dur-
ing late 1999 that the H1N2 viruses arose by reassort-
ment between H1N1 and H3N2 viruses some time be-
tween late 1999 and early 2001.
Phylogenetic analyses of the other six genes empha-
sized the close relationships between the corresponding
genes of H1N2 viruses and A/Moscow/10/99 (H3N2), as
shown for the nucleoprotein (NP) gene in Fig. 1C. The
closer relationship between the M genes of H1N2 vi-
ruses and A/Panama/2007/99 (Fig. 1D), on the other
hand, are reflected in common amino acid differences in
M1, R174K, and A218T, from A/Moscow/10/99 and earlier
H3N2 viruses. Differences in the degree of relatedness
among the internal genes of these viruses may reflect
the heterogeneity and genetic reassortment of genes of
cocirculating variants (14). An unusual feature of the M2
sequence of H1N2 viruses is the change in cysteine 17 to
tyrosine, which, in contrast to cysteine 19, was previously
observed to be conserved in all available sequences of
M2 proteins of human, animal, and avian viruses. As for
the majority of recent human H1N1 and H3N2 viruses
analyzed, the M2 proteins of H1N2 viruses did not con-
tain amino acid changes in residues 26, 27, 30, 31, or 34
likely to confer resistance to amantadine or rimantadine.
The NS1 protein and nuclear export protein products of
the NS gene of H1N2 virus showed no distinguishing
features. The partial sequences obtained for the PB1,
PB2, PA, and NP genes did not provide information on
amino acid changes in the polymerase complex which
may be associated with the emergence of the reassor-
tant viruses.
Discussion. Similar to the H1N2 reassortants isolated
in China in 1988–1989, the H1N2 viruses which emerged
during 2001 possess a H1 similar to contemporary H1N1
viruses and seven genes similar to those of recent H3N2
viruses. In particular, the H1 and N2 components are
FIG. 1—Continued
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antigenically similar to those of contemporary H1N1 and
H3N2 viruses, respectively, and do not add significantly
to the antigenic spectrum of currently circulating viruses.
The predominance of H1N2 viruses over H1N1 viruses
in several countries, including Egypt, Israel, and the U.K.,
raises the possibility that, on this occasion, this subtype
may become established in the human population and
contribute significantly to future outbreaks and epidem-
ics of influenza and might even replace the H1N1 and/or
H3N2 subtype. The viruses are widely distributed (8) and
have cocirculated with H3N2 viruses in a number of
countries.
Following the emergence during 1999 of the A/New
Caledonia/20/99-like variant, H1N1 viruses became the
principal cause of influenza in many parts of the world
during 2000–2001, particularly during that winter in the
Northern hemisphere. The greater prevalence of these
viruses than previously may therefore have facilitated the
emergence of the H1N2 reassortant viruses and, in this
respect, the appearance of H1N2 reassortants in 1988–
1989 also coincided with an increased prevalence of
H1N1 viruses.
As regards the future success of the recent reassor-
tants, changes in the properties of the H1 HA may prove
to be of significance in relation to both the greater impact
of A/New Caledonia/20/99 (H1N1)-like viruses and the
greater compatibility between H1 and the other compo-
nents of (H3) N2 viruses. Of seven amino acid changes
which distinguish the HAs of A/New Caledonia/20/99-
like viruses from the HAs of early A/Beijing/262/95-like
viruses, two represent changes to residues, serine 136
and leucine 194, highly conserved in the receptor binding
sites of H3 HAs (11). Two further residues, 156 and 186,
as well as residue 193, one of the two residues altered
(A193T) in the H1s of the H1N2 viruses, are also impor-
tant in interactions of sialic acid receptors with H3, H5,
and/or H9 HAs (see Fig. 3b in 13, 15). Another change,
characteristic of viruses of the A/Beijing/262/95 lineage,
is a deletion at position 133/134, which may have af-
fected the receptor-binding properties of subsequent vi-
ruses (9, 10). Changes in residue 218, located at the
interface between subunits of H3, have been observed to
influence both receptor-binding affinity and the pH of
membrane fusion (15). In regard to the latter property, the
only change in HA2, which occurred prior to the drift to
A/New Caledonia-like viruses, was the conservative
change I18V, in a relatively conserved part of the se-
quence close to the fusion peptide. Although the effects
of these changes on HA function and their relationships
to the functions of other components, in particular the NA
and M2 channel, are not known, it does appear likely that
functional changes in H1 have facilitated the emergence
of H1N2 reassortants. The two changes (E199K and
K431N) in the N2 which accompanied emergence of the
H1N2 reassortants are both in surface residues which
have, similar to a number of the differences between
A/Moscow/10/99 and A/Sydney/5/97 NAs, been associ-
TABLE 3
Genetic Relationships between H1N2, H1N1, and H3N2 Viruses
Gene
Percent similarity with A/Saudi Arabia/2231/01a
A/Saudi Arabia/
7971/00
A/New Caledonia/
20/99
A/Moscow/
10/99
PB2 86.8 86.4 98.6
PB1 78.1 78.7 100.0
PA 89.9 90.0 99.0
H1 98.7 98.5 —
NP 88.2 88.2 99.7
N2 — — 99.0
M 91.6 91.8 98.4
NS 88.6 88.9 99.9
a Based on comparisons of the sequences of nucleotides 463–809
(PB1), 60–492 (PB2), 60–893 (PA), 99–974 (H1), 1037–1409 (NP), 395–
1395 (N2), 154–856 (M), and 81–800 (NS).
TABLE 2
Gene Sequences of H1N1, H1N2, and H3N2 Viruses
Determined in this Study
Virus
Date of
isolation Gene sequencesa
H1N1
A/Bayern/7/95 30/03/95 PB1, PB2, PA, HA, NP, M, NS
A/New Caledonia/20/99 09/06/99 PB1, PB2, PA, HA, NP, M, NS
A/Saudi Arabia/7971/00 05/12/00 PB1, PB2, PA, HA, NP, M, NS
H1N2
A/Saudi Arabia/2231/01 26/03/01 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Saudi Arabia/2581/01 31/03/01 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Egypt/84/01 26/12/01 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Egypt/96/01 02/01/02 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Israel/173/01 27/12/01 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Israel/6/02 02/01/02 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Israel/7/02 02/01/02 PB1, PB2, PA, HA, NP, NA,
M, NS
A/England/2/02 03/01/02 PB1, PB2, PA, HA, NP, NA,
M, NS
A/Latvia/686/02 18/01/02 HA
A/Lyon/1575/02 20/01/02 NA
A/Stockholm/13/02 NA
H3N2
A/Moscow/10/99 01/99 PB1, PB2, PA, NP, NA, M, NS
A/Panama/2007/99 PB1, PB2, PA, NP, NA, M, NS
a The genes encode the PB1, PB2, and PA polymerase components,
the hemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), the M
proteins (M1 and M2), and the “nonstructural” (NS) proteins (NS1 and
the nuclear export protein).
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ated previously with antigenic drift (16). It may be, how-
ever, that some of these changes have affected the
functional compatibility between the HA and NA compo-
nents of these viruses.
H1N2 viruses, which recently became established in
pigs in Europe, contain H1 and N2 components related
to early human H1N1 (post-1977) and H3N2 viruses,
respectively, together with six internal genes derived
from “avian-like” H1N1 swine viruses (17, 18). In this case,
no marked changes were observed in amino acid resi-
dues which may have affected the complementary re-
ceptor-binding and receptor destroying activities of the
HA and NA, respectively, and contributed to the success-
ful emergence of these reassortants and subsequent
cocirculation with H1N1 and H3N2 viruses.
The contribution of the H3N2 internal genes to the
epidemiologic properties of the H1N2 reassortants is not
known; however, various combinations of the genes of
earlier H3N2 viruses did not previously support the suc-
cessful establishment of H1N1, H1N2, or H3N2 reassor-
tant viruses in the human population. Thus, although the
recent prevalence of H1N2 viruses is testament to their
current success, their future epidemiologic significance
remains to be determined.
Materials and Methods. Viruses were isolated from
nose and throat swabs or nasopharyngeal aspirates,
obtained from patients with upper respiratory tract infec-
tions after admission to hospital, from institutional out-
breaks or during community surveillance in Egypt,
France, Germany, Ireland, Israel, Italy, Latvia, Portugal,
Saudi Arabia, Spain, Sweden, Switzerland, and the U.K.
Viruses were isolated and passaged on MDCK cells,
primary monkey kidney (PMK) cells, or in fertile hen
eggs. H1N2 and H1N1 viruses isolated from January to
March 2002 and included in this study were also re-
ceived from Dr. M. Aymard, Lyon, France; Dr. R. Heckler,
Hannover, Germany; Dr. P. Quinn, Dublin, Ireland; Dr. I.
Donatelli, Rome, Italy; Dr. V. Kalnina, Riga, Latvia; Dr. H.
Rebelo de Andrade, Lisbon, Portugal; Dr. A. Joss, In-
verness, Scotland; Dr. M. Jimemez de Anta, Barcelona,
Dr. P. Perez-Brena, Madrid, and Dr. R. Ortiz de Lejarazu,
Valladolid, Spain; Dr. P. Petersson, Stockholm, Sweden;
and Dr. Y. Thomas, Geneva, Switzerland.
Antigenic Analyses. Hemagglutination inhibition tests,
using turkey erythrocytes, and neuraminidase inhibition
tests were performed as previously described (19). Anti-
sera used included hyperimmune rabbit antisera against
A/Brazil/11/78 (H1N1), A/Port Chalmers/1/73 (H3N2), and
A/Beijing/32/92 (H3N2) and postinfection ferret sera
against A/Bayern/7/95 (H1N1), A/Beijing/262/95 (H1N1),
A/New Caledonia/20/99 (H1N1), A/Hong Kong/1252/00
(H1N1), A/Madagascar/57794/00 (H1N1), A/Sydney/5/97
(H3N2), A/Moscow/10/99 (H3N2), and A/Panama/
2007/99 (H3N2).
PCR and Nucleotide Sequencing. Virus RNA was ex-
tracted from infected cell culture fluid or allantoic fluid
using QIAamp spin columns (Qiagen). Reverse transcrip-
tion used a primer (complementary to nucleotides 1–12
at the 3 ends) common to all eight genes. The se-
quences of PCR primers used to generate DNA frag-
ments corresponding to each of the eight genes are
available on request; the fragment lengths (nucleotides)
were as follows: PBI, 331-1511; PB2, 1–533; PA, 1–953;
H1, 8–1129; H3, 6–1120; NP, 1033–1467; N1, 1–1118; N2,
387-1447; M, 98–940; NS, 1–890. The PCR products were
purified by agarose gel electrophoresis and a QIAquick
gel extraction kit (Qiagen) and sequenced using an ABI
Prism BigDye terminator cycle sequencing kit and an ABI
model 377 DNA sequencer (Perkin–Elmer, Applied Bio-
systems), as previously described (20). Sequence data
were edited and analyzed using the Wisconsin Se-
quence Analysis Package version 10 (GCG). The phylo-
genetic analyses were performed using Phylogenetic
Analysis Using Parsimony (PAUP, Version 4.0, D. Swof-
ford, Illinois Natural History Survey, Champaign, IL). The
nucleotide sequences determined in this study, which
are listed in Table 2 and included in Fig. 1, are available
from GenBank under the following accession numbers:
AJ457861-457911 and AJ457930 (HA); AJ457931-457966
(NA); AJ458265-458277 (NP); AJ458293-458308 and
AJ458339 (M). Previously published sequences were ob-
tained from GenBank.
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